Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OssDsign ABOSTO:OSSD -2.21%54 Cyclically Adjusted PB Ratio is 1.01 as of Sep. 15, 2026. GuruFocus rates OSTO:OSSD with a GF Score™ of 54/100 and a GF Value™ of kr9.49 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 513 Medical Devices & Instruments companies, OssDsign AB ranks worse than 194931.58% on this metric.
OssDsign AB does not have a history long enough to calculate Cyclically Adjusted Book per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PB Ratio for this company.
Shiller PE for Stocks: The True Measure of Stock Valuation
OssDsign AB (OSTO:OSSD) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
OssDsign AB Cyclically Adjusted PB Ratio Related Terms
OssDsign AB Cyclically Adjusted PB Ratio Historical Data
* Premium members only.
The historical data trend for OssDsign AB's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:OSSD vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison
For the Medical Devices subindustry, OssDsign AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OssDsign AB Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OssDsign AB's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where OssDsign AB's Cyclically Adjusted PB Ratio falls into.
OssDsign AB Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
OssDsign AB does not have a history long enough to calculate Cyclically Adjusted Book per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PB Ratio for this company.
What does a Cyclically Adjusted PB Ratio of 1.01 mean?
OssDsign AB (OSTO:OSSD) has a Cyclically Adjusted PB Ratio of 1.01 as of Sep. 15, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on OssDsign AB and its competitors. According to the industry distribution chart, OssDsign AB ranks #999999 out of 513 companies in the Medical Devices & Instruments industry.
Is OssDsign AB's Cyclically Adjusted PB Ratio too high?
OssDsign AB's current Cyclically Adjusted PB Ratio is 1.01. The Medical Devices & Instruments industry median Cyclically Adjusted PB Ratio is 1.80. OssDsign AB's value of 1.01 is 43.9% below this industry median. Based on the distribution chart, OssDsign AB ranks #999999 out of 513 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, OssDsign AB has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OssDsign AB's Cyclically Adjusted PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, OssDsign AB ranks #999999 out of 513 companies for Cyclically Adjusted PB Ratio. This places OssDsign AB in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.80. OssDsign AB's value of 1.01 is 43.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PB Ratio among Medical Devices & Instruments companies is 1.80, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OssDsign AB's current Cyclically Adjusted PB Ratio of 1.01 is 43.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on OssDsign AB and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PB Ratio is 1.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OssDsign AB's current Cyclically Adjusted PB Ratio is 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OssDsign AB stock overvalued right now?
Based on GuruFocus' analysis, OssDsign AB (OSTO:OSSD) is currently considered Possible Value Trap. The stock's GF Value™ is kr9.49, compared to a current price of kr3.54 — trading 62.7% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 1.01 and 43.9% below the Medical Devices & Instruments industry median of 1.80. OssDsign AB's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For OssDsign AB (OSTO:OSSD), the current Cyclically Adjusted PB Ratio is 1.01 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OssDsign AB (OSTO:OSSD) Overvalued in 2026?
Based on GuruFocus' analysis, OssDsign AB stock appears to be undervalued.
The current stock price of kr3.54 is trading 62.7% below its estimated GF Value™ of kr9.49.
GuruFocus considers OssDsign AB to be Possible Value Trap.
Key valuation signals for OSTO:OSSD:
Cyclically Adjusted PB Ratio: 1.01
GF Value™: kr9.49 vs. price of kr3.54 (62.7% below fair value)
Industry Position: 43.9% below the Medical Devices & Instruments median (#999999 of 513)
No single metric tells the full story. See the OSTO:OSSD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OssDsign AB is a developer and international provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the USA, Germany, Sweden and UK. The company generates the majority of its revenue from the USA region.
54GF Score
Get the complete analysis for OSTO:OSSD
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:OSSD has been successfully added to your 
